BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹3.11 | ₹4.79 | ₹2.21 | ₹2.46 | ₹-7.94 |
What is the latest Earnings Per Share (EPS) of BAFNA PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹3.11 |
| Mar2024 | ₹4.79 |
| Mar2023 | ₹2.21 |
| Mar2022 | ₹2.46 |
| Mar2021 | ₹-7.94 |
How is Earnings Per Share (EPS) of BAFNA PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.11 | -35.07 | |
| Mar2024 | ₹4.79 | 116.74 | |
| Mar2023 | ₹2.21 | -10.16 | |
| Mar2022 | ₹2.46 | Positive | |
| Mar2021 | ₹-7.94 | - | |
Compare Earnings Per Share (EPS) of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹327.1 Cr | 4% | 4.1% | 83.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,369.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 4% |
4.1% |
83.8% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses